| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
593 |
335 |
$52K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
325 |
252 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
271 |
153 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
137 |
114 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
293 |
202 |
$9K |
| 0071A |
|
103 |
63 |
$2K |
| 0240U |
|
32 |
13 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
32 |
29 |
$2K |
| 0072A |
|
71 |
49 |
$2K |
| 0001A |
|
47 |
33 |
$1K |
| 0064A |
|
39 |
34 |
$866.50 |
| 0004A |
|
34 |
26 |
$800.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
25 |
12 |
$584.64 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
12 |
$359.81 |
| 36415 |
Collection of venous blood by venipuncture |
52 |
43 |
$93.21 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
12 |
$90.63 |